Billiontoone (BLLN) Stock Price, News & Analysis

Company Overview

BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company’s molecular counting technology to detect and measure genetic material in patient samples.

In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient’s blood sample.

The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material. BillionToOne was founded in 2016 and is led by co-founder and Chief Executive Officer Rahul Dhanda. Its services are primarily offered in the United States.

Key Stats

• Today's Range: $106.36 to $113.36
• 50-Day Range: $92.32 to $124.90
• 52-Week Range: $61.96 to $150.44
• Volume: 976,590 shs
• Average Volume: 572,579 shs
• Market Capitalization: $5.28 billion
• P/E Ratio: 121.74
• Dividend Yield: N/A
• Price Target: $124.38
• Consensus Rating: Moderate Buy

Billiontoone Stock Analysis - MarketRank™

Billiontoone scored higher than 54% of companies evaluated by MarketBeat, and ranked 459th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Billiontoone has received a consensus rating of Moderate Buy. The company's average rating score is 2.55, and is based on no strong buy ratings, 7 buy ratings, 3 hold ratings, and 1 sell rating.

Upside Potential

Billiontoone has a consensus price target of $124.38, representing about 11.0% upside from its current price of $112.00.

Amount of Analyst Coverage

Billiontoone has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 23.86%

Earnings Growth

Earnings for Billiontoone are expected to grow by 23.86% in the coming year, from $0.88 to $1.09 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Billiontoone is 121.74, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.70.

Price to Earnings Ratio vs. Sector

The P/E ratio of Billiontoone is 121.74, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.30.

Price to Book Value per Share Ratio

Billiontoone has a P/B Ratio of 9.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

12.65% of the float of Billiontoone has been sold short.

Short Interest Ratio / Days to Cover

Billiontoone has a short interest ratio ("days to cover") of 6.69.

Change versus previous month

Short interest in Billiontoone has recently increased by 1.30%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Billiontoone does not currently pay a dividend.

Dividend Growth

Billiontoone does not have a long track record of dividend growth.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.35

News Sentiment

Billiontoone has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 36 news articles for Billiontoone this week, compared to 5 articles on an average week.

Search Interest

Only 2 people have searched for BLLN on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

MarketBeat Follows

5 people have added Billiontoone to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Billiontoone insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $26,737,151.00 in company stock.

Percentage Held by Insiders

50.22% of the stock of Billiontoone is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Billiontoone has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 11/11/2026
• Stifel 2026 Healthcare Conference 2026: 11/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:BLLN
• CIK: 2070849
• Web: www.billiontoone.com
• Phone: (650) 460-2551
• Fax: N/A
• Employees: 713
• Year Founded: 2016

Price Target and Rating

• Average Price Target for Billiontoone: $124.38
• High Price Target: $145.00
• Low Price Target: $90.00
• Potential Upside/Downside: +11.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.55
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.92
• Trailing P/E Ratio: 121.74
• Forward P/E Ratio: 102.75
• P/E Growth: N/A
• Net Income: $7.45 million
• Net Margins: 10.95%
• Pretax Margin: 11.38%
• Return on Equity: 9.16%
• Return on Assets: 6.78%

Debt

• Debt-to-Equity Ratio: 0.16
• Current Ratio: 11.25
• Quick Ratio: 10.89

Sales & Book Value

• Annual Sales: $436.87 million
• Price / Sales: 12.10
• Cash Flow: $0.32 per share
• Price / Cash Flow: 355.14
• Book Value: $12.01 per share
• Price / Book: 9.33

Miscellaneous

• Outstanding Shares: 47,187,000
• Free Float: 23,490,000
• Market Cap: $5.28 billion
• Optionable: Optionable
• Beta: N/A